Form 8-K - Current report:
SEC Accession No. 0001193125-24-003965
Filing Date
2024-01-08
Accepted
2024-01-08 08:30:56
Documents
57
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d754126d8k.htm   iXBRL 8-K 27256
2 EX-99.1 d754126dex991.htm EX-99.1 33945
3 EX-99.2 d754126dex992.htm EX-99.2 46005
7 GRAPHIC g754126dsp4.jpg GRAPHIC 4238
8 GRAPHIC g754126ex99_2s10g1.jpg GRAPHIC 96222
9 GRAPHIC g754126ex99_2s11g1.jpg GRAPHIC 89812
10 GRAPHIC g754126ex99_2s12g1.jpg GRAPHIC 107960
11 GRAPHIC g754126ex99_2s13g1.jpg GRAPHIC 80689
12 GRAPHIC g754126ex99_2s14g1.jpg GRAPHIC 40241
13 GRAPHIC g754126ex99_2s15g1.jpg GRAPHIC 95196
14 GRAPHIC g754126ex99_2s16g1.jpg GRAPHIC 85788
15 GRAPHIC g754126ex99_2s17g1.jpg GRAPHIC 37309
16 GRAPHIC g754126ex99_2s18g1.jpg GRAPHIC 41035
17 GRAPHIC g754126ex99_2s19g1.jpg GRAPHIC 97052
18 GRAPHIC g754126ex99_2s1g1.jpg GRAPHIC 52203
19 GRAPHIC g754126ex99_2s20g1.jpg GRAPHIC 98377
20 GRAPHIC g754126ex99_2s21g1.jpg GRAPHIC 85857
21 GRAPHIC g754126ex99_2s22g1.jpg GRAPHIC 38936
22 GRAPHIC g754126ex99_2s23g1.jpg GRAPHIC 90142
23 GRAPHIC g754126ex99_2s24g1.jpg GRAPHIC 37644
24 GRAPHIC g754126ex99_2s25g1.jpg GRAPHIC 71251
25 GRAPHIC g754126ex99_2s26g1.jpg GRAPHIC 77695
26 GRAPHIC g754126ex99_2s27g1.jpg GRAPHIC 82606
27 GRAPHIC g754126ex99_2s28g1.jpg GRAPHIC 36414
28 GRAPHIC g754126ex99_2s29g1.jpg GRAPHIC 79988
29 GRAPHIC g754126ex99_2s2g1.jpg GRAPHIC 164773
30 GRAPHIC g754126ex99_2s30g1.jpg GRAPHIC 80907
31 GRAPHIC g754126ex99_2s31g1.jpg GRAPHIC 36331
32 GRAPHIC g754126ex99_2s32g1.jpg GRAPHIC 99051
33 GRAPHIC g754126ex99_2s33g1.jpg GRAPHIC 34324
34 GRAPHIC g754126ex99_2s34g1.jpg GRAPHIC 31139
35 GRAPHIC g754126ex99_2s35g1.jpg GRAPHIC 86088
36 GRAPHIC g754126ex99_2s36g1.jpg GRAPHIC 110293
37 GRAPHIC g754126ex99_2s37g1.jpg GRAPHIC 122082
38 GRAPHIC g754126ex99_2s38g1.jpg GRAPHIC 100044
39 GRAPHIC g754126ex99_2s39g1.jpg GRAPHIC 77855
40 GRAPHIC g754126ex99_2s3g1.jpg GRAPHIC 88080
41 GRAPHIC g754126ex99_2s40g1.jpg GRAPHIC 91687
42 GRAPHIC g754126ex99_2s41g1.jpg GRAPHIC 94585
43 GRAPHIC g754126ex99_2s42g1.jpg GRAPHIC 99125
44 GRAPHIC g754126ex99_2s4g1.jpg GRAPHIC 102031
45 GRAPHIC g754126ex99_2s5g1.jpg GRAPHIC 112423
46 GRAPHIC g754126ex99_2s6g1.jpg GRAPHIC 87431
47 GRAPHIC g754126ex99_2s7g1.jpg GRAPHIC 30269
48 GRAPHIC g754126ex99_2s8g1.jpg GRAPHIC 84255
49 GRAPHIC g754126ex99_2s9g1.jpg GRAPHIC 54216
  Complete submission text file 0001193125-24-003965.txt   4822996

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mirm-20240108.xsd EX-101.SCH 2849
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20240108_lab.xml EX-101.LAB 17993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20240108_pre.xml EX-101.PRE 11260
51 EXTRACTED XBRL INSTANCE DOCUMENT d754126d8k_htm.xml XML 3356
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 24518493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)